Page 46 - 79_03
P. 46
J.
C.
Rodríguez
Rey
41. Brown,
M.S.,
and
Goldstein,
J.L.
1997.
The
SREBP
pathway:
regulation
of
cholesterol
metabolism
by
proteolysis
of
a
membrane--bound
transcription
factor.
Cell
89:331--340.
42. Horton,
J.D.,
Goldstein,
J.L.,
and
Brown,
M.S.
2002.
SREBPs:
activators
of
the
complete
program
of
cholesterol
and
fatty
acid
synthesis
in
the
liver.
J
Clin
Invest
109:1125--1131.
43. Biddinger,
S.B.,
Hernandez--Ono,
A.,
Rask--Madsen,
C.,
Haas,
J.T.,
Aleman,
J.O.,
Suzuki,
R.,
Scapa,
E.F.,
Agarwal,
C.,
Carey,
M.C.,
Stephanopoulos,
G.,
et
al.
2008.
Hepatic
insulin
resistance
is
sufficient
to
produce
dyslipidemia
and
susceptibility
to
atherosclerosis.
Cell
Metab
7:125--134.
44. Michael,
M.D.,
Kulkarni,
R.N.,
Postic,
C.,
Previs,
S.F.,
Shulman,
G.I.,
Magnuson,
M.A.,
and
Kahn,
C.R.
2000.
Loss
of
insulin
signaling
in
hepatocytes
leads
to
severe
insulin
resistance
and
progressive
hepatic
dysfunction.
Mol
Cell
6:87--97.
45. Shimomura,
I.,
Matsuda,
M.,
Hammer,
R.E.,
Bashmakov,
Y.,
Brown,
M.S.,
and
Goldstein,
J.L.
2000.
Decreased
IRS--2
and
increased
SREBP--1c
lead
to
mixed
insulin
resistance
and
sensitivity
in
livers
of
lipodystrophic
and
ob/ob
mice.
Mol
Cell
6:77--86.
46. Brown,
M.S.,
and
Goldstein,
J.L.
2008.
Selective
versus
total
insulin
resistance:
a
pathogenic
paradox.
Cell
Metab
7:95--96.
47. Tran,
H.,
Brunet,
A.,
Griffith,
E.C.,
and
Greenberg,
M.E.
2003.
The
many
forks
in
FOXO's
road.
Sci
STKE
2003:RE5.
48. Li,
S.,
Brown,
M.S.,
and
Goldstein,
J.L.
2010.
Bifurcation
of
insulin
signaling
pathway
in
rat
liver:
mTORC1
required
for
stimulation
of
lipogenesis,
but
not
inhibition
of
gluconeogenesis.
Proc
Natl
Acad
Sci
U
S
A
107:3441--3446.
49. Pajvani,
U.B.,
Qiang,
L.,
Kangsamaksin,
T.,
Kitajewski,
J.,
Ginsberg,
H.N.,
and
Accili,
D.
2013.
Inhibition
of
Notch
uncouples
Akt
activation
from
hepatic
lipid
accumulation
by
decreasing
mTorc1
stability.
Nat
Med
19:1054--1060.
50. Li,
Y.,
Xu,
S.,
Mihaylova,
M.M.,
Zheng,
B.,
Hou,
X.,
Jiang,
B.,
Park,
O.,
Luo,
Z.,
Lefai,
E.,
Shyy,
J.Y.,
et
al.
2011.
AMPK
phosphorylates
and
inhibits
SREBP
activity
to
attenuate
hepatic
steatosis
and
atherosclerosis
in
diet--induced
insulin--resistant
mice.
Cell
Metab
13:376--388.
51. Liu,
L.,
Zhang,
Y.,
Chen,
N.,
Shi,
X.,
Tsang,
B.,
and
Yu,
Y.H.
2007.
Upregulation
of
myocellular
DGAT1
augments
triglyceride
synthesis
in
skeletal
muscle
and
protects
against
fat--
induced
insulin
resistance.
J
Clin
Invest
117:1679--1689.
52. Goodpaster,
B.H.,
He,
J.,
Watkins,
S.,
and
Kelley,
D.E.
2001.
Skeletal
muscle
lipid
content
and
insulin
resistance:
evidence
for
a
paradox
in
endurance--trained
athletes.
J
Clin
Endocrinol
Metab
86:5755--5761.
53. Samuel,
V.T.,
and
Shulman,
G.I.
2012.
Mechanisms
for
insulin
resistance:
common
threads
and
missing
links.
Cell
148:852--871.
54. Holland,
W.L.,
Brozinick,
J.T.,
Wang,
L.P.,
Hawkins,
E.D.,
Sargent,
K.M.,
Liu,
Y.,
Narra,
K.,
Hoehn,
K.L.,
Knotts,
T.A.,
Siesky,
A.,
et
al.
2007.
Inhibition
of
ceramide
synthesis
ameliorates
glucocorticoid--,
saturated--fat--,
and
obesity--induced
insulin
resistance.
Cell
Metab
5:167--179.
55. Haring,
H.,
Kirsch,
D.,
Obermaier,
B.,
Ermel,
B.,
and
Machicao,
F.
1986.
Tumor--promoting
phorbol
esters
increase
the
Km
of
the
ATP--binding
site
of
the
insulin
receptor
kinase
from
rat
adipocytes.
J
Biol
Chem
261:3869--3875.
56. Avignon,
A.,
Yamada,
K.,
Zhou,
X.,
Spencer,
B.,
Cardona,
O.,
Saba--Siddique,
S.,
Galloway,
L.,
Standaert,
M.L.,
and
Farese,
R.V.
1996.
Chronic
activation
of
protein
kinase
C
in
soleus
muscles
and
other
tissues
of
insulin--resistant
type
II
diabetic
Goto--Kakizaki
(GK),
obese/aged,
and
obese/Zucker
rats.
A
mechanism
for
inhibiting
glycogen
synthesis.
Diabetes
45:1396--1404.
57. Griffin,
M.E.,
Marcucci,
M.J.,
Cline,
G.W.,
Bell,
K.,
Barucci,
N.,
Lee,
D.,
Goodyear,
L.J.,
Kraegen,
E.W.,
White,
M.F.,
and
Shulman,
G.I.
1999.
Free
fatty
acid--induced
insulin
resistance
is
associated
with
activation
of
protein
kinase
C
theta
and
alterations
in
the
insulin
signaling
cascade.
Diabetes
48:1270--1274.
431
